Torthaí cuardaigh - Haeun Hwangbo

  • 1 - 3 toradh as 3 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Predictable Clinical Benefits without Evidence of Synergy in Trials of Combination Therapies with Immune-Checkpoint Inhibitors

    Predictable Clinical Benefits without Evidence of Synergy in Trials of Combination Therapies with Immune-Checkpoint Inhibitors de réir Adam C. Palmer, Benjamin Izar, Haeun Hwangbo, Peter K. Sorger

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Additivity predicts the efficacy of most approved combination therapies for advanced cancer

    Additivity predicts the efficacy of most approved combination therapies for advanced cancer de réir Haeun Hwangbo, Sarah C. Patterson, Andy Dai, Deborah Plana, Adam C. Palmer

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    An RNA damage response network mediates the lethality of 5-FU in colorectal cancer

    An RNA damage response network mediates the lethality of 5-FU in colorectal cancer de réir Jung-Kuei Chen, Karl A. Merrick, Yi Wen Kong, Anita Izrael-Tomasevic, George Eng, Erika D. Handly, Jesse C. Patterson, Ian G. Cannell, Lucía Suárez-López, Aaron M. Hosios, Anh Dinh, Donald S. Kirkpatrick, Kebing Yu, Christopher M. Rose, Jonathan M. Hernandez, Haeun Hwangbo, Adam C. Palmer, Matthew G. Vander Heiden, Ömer Yılmaz, Michael B. Yaffe

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: